Product Description

🔹 Product Overview
Gemcite 1.4 g Injection is a prescription anticancer medicine containing gemcitabine, a nucleoside metabolic inhibitor used as part of chemotherapy for several types of cancer.
Gemcitabine is administered by intravenous infusion under the supervision of a qualified healthcare professional. It may be used alone or in combination with other anticancer medicines depending on the cancer being treated and the treatment protocol prescribed by the oncologist.
Important: The exact strength and presentation should be confirmed from the product packaging and manufacturer's label before publication.

🔹 Key Uses
Gemcitabine-based chemotherapy may be used in the treatment of:
Pancreatic cancer
Non-small cell lung cancer
Breast cancer
Ovarian cancer
Urinary bladder cancer
The specific indication and combination regimen depend on the patient's diagnosis, disease stage, previous treatment, and oncologist's treatment plan.

🔹 Composition
Active ingredient: Gemcitabine
Drug class: Antineoplastic / nucleoside metabolic inhibitor
Dosage form: Injection or powder for solution for intravenous infusion
Gemcitabine works by interfering with DNA synthesis, which helps slow or stop the growth of rapidly dividing cancer cells.

🔹 How It Works
Gemcitabine is converted inside cells into active metabolites that interfere with DNA synthesis.
It can inhibit the formation of DNA building blocks and become incorporated into DNA, disrupting the ability of cancer cells to reproduce.
Because cancer cells often divide rapidly, they can be particularly affected by this mechanism. Gemcitabine therefore helps slow cancer-cell growth and may contribute to tumor control as part of an appropriate chemotherapy regimen.

🔹 Key Benefits
Used as an established chemotherapy medicine
May be used for several types of solid tumors
Can be administered alone or with other anticancer medicines
Used as part of medically supervised cancer-treatment protocols
Available in injectable formulations for intravenous administration

🔹 Dosage and Administration
Gemcite should be administered only by a qualified healthcare professional.
It is given by intravenous infusion after appropriate preparation and dilution.
The dose is individualized according to the type of cancer, body-surface area, treatment regimen, blood counts, organ function, and response to treatment.
Treatment schedules vary considerably between cancer types.
Dose adjustments or treatment delays may be necessary depending on blood-cell counts and other treatment-related toxicities.
Do not self-administer or attempt to calculate the chemotherapy dose without specialist medical supervision.

🔹 Possible Side Effects
Gemcitabine chemotherapy can cause side effects, which may include:
Nausea and vomiting
Fatigue or weakness
Fever
Low white blood cell count
Low platelet count
Anemia
Diarrhea
Constipation
Loss of appetite
Skin rash
Hair loss
Flu-like symptoms
Increased risk of infections
Some adverse effects can be serious because gemcitabine may suppress bone-marrow function. Patients receiving treatment require appropriate medical monitoring.

🔹 Precautions
Use only under the supervision of an oncologist or qualified healthcare professional.
Blood counts should be monitored during treatment.
Inform your doctor about liver, kidney, lung, or other medical conditions.
Tell your healthcare team about all medicines and supplements you are taking.
Seek medical attention promptly for fever, signs of infection, unusual bleeding, severe breathing difficulty, or other serious symptoms.
Gemcitabine can cause fetal harm; pregnancy should be discussed with the treating physician before therapy.
Breastfeeding is generally not recommended during gemcitabine treatment.
The medicine may cause significant toxicity, so treatment must follow the prescribed chemotherapy protocol.